Anne L. Holleran

Array ( [id] => 9977043 [patent_doc_number] => 09023350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Synergistic pharmaceutical composition useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animals' [patent_app_type] => utility [patent_app_number] => 12/735659 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4341 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12735659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499419 [patent_doc_number] => 20110262430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'NOVEL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/671607 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 30892 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262430.pdf [firstpage_image] =>[orig_patent_app_number] => 12671607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6081418 [patent_doc_number] => 20110143351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'GLYOSYLATION MARKERS FOR CANCER AND CHRONIC INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/452720 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 30458 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20110143351.pdf [firstpage_image] =>[orig_patent_app_number] => 12452720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8944063 [patent_doc_number] => 08497243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Methods and compositions useful in the treatment of mucositis' [patent_app_type] => utility [patent_app_number] => 12/217614 [patent_app_country] => US [patent_app_date] => 2008-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11398 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12217614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558739 [patent_doc_number] => 20090270316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'HER-2 BINDING ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/165317 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11815 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270316.pdf [firstpage_image] =>[orig_patent_app_number] => 12165317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8027855 [patent_doc_number] => 08143010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Prostate-specific polypeptide PAMP and encoding nucleic acid molecules' [patent_app_type] => utility [patent_app_number] => 12/163889 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 16736 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143010.pdf [firstpage_image] =>[orig_patent_app_number] => 12163889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282477 [patent_doc_number] => 08216580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Sulfatases and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/163761 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 39 [patent_no_of_words] => 46111 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12163761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10498529 [patent_doc_number] => 09226920 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-01-05 [patent_title] => 'Methods of inducing and preventing neurofibromatosis in Schwann cells' [patent_app_type] => utility [patent_app_number] => 12/137795 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8024 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12137795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271024 [patent_doc_number] => 20090074800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Cancer antigen and use thereof' [patent_app_type] => utility [patent_app_number] => 12/155864 [patent_app_country] => US [patent_app_date] => 2008-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11047 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074800.pdf [firstpage_image] =>[orig_patent_app_number] => 12155864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195436 [patent_doc_number] => 20110027190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'COMPOSITION OF A FIRST NON-LABELED MONOCLONAL ANTIBODY BINDING TO A TUMOR ANTIGEN AND A NON-CROSS REACTIVE SECOND MONOCLONAL ANTIBODY LABELED WITH A NIR FLUORESCENCE LABEL' [patent_app_type] => utility [patent_app_number] => 12/599713 [patent_app_country] => US [patent_app_date] => 2008-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14357 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027190.pdf [firstpage_image] =>[orig_patent_app_number] => 12599713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759395 [patent_doc_number] => 20080311621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME' [patent_app_type] => utility [patent_app_number] => 12/132350 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 29160 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311621.pdf [firstpage_image] =>[orig_patent_app_number] => 12132350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5457853 [patent_doc_number] => 20090258005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Therapeutic compositions and methods' [patent_app_type] => utility [patent_app_number] => 12/156159 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 29791 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258005.pdf [firstpage_image] =>[orig_patent_app_number] => 12156159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852018 [patent_doc_number] => 20080317760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Compositions and Methods for Diagnosing and Treating Cancer' [patent_app_type] => utility [patent_app_number] => 12/121348 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24254 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317760.pdf [firstpage_image] =>[orig_patent_app_number] => 12121348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5526836 [patent_doc_number] => 20090196913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'Anti-Alpha-V Immunoliposome Composition, Methods, and Uses' [patent_app_type] => utility [patent_app_number] => 12/119012 [patent_app_country] => US [patent_app_date] => 2008-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 25350 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20090196913.pdf [firstpage_image] =>[orig_patent_app_number] => 12119012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320462 [patent_doc_number] => 20100196363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'CANCER TREATMENT COMBINATION THERAPY COMPRISING VINFLUNINE AND TRASTUZUMAB' [patent_app_type] => utility [patent_app_number] => 12/602127 [patent_app_country] => US [patent_app_date] => 2008-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1906 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196363.pdf [firstpage_image] =>[orig_patent_app_number] => 12602127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758892 [patent_doc_number] => 20080311118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/110223 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15047 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311118.pdf [firstpage_image] =>[orig_patent_app_number] => 12110223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697809 [patent_doc_number] => 20080219993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'HUMAN RGR ONCOGENE AND TRUNCATED TRANSCRIPTS THEREOF DETECTED IN T CELL MALIGNANCIES, ANTIBODIES TO THE ENCODED POLYPEPTIDES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/109809 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13087 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20080219993.pdf [firstpage_image] =>[orig_patent_app_number] => 12109809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710590 [patent_doc_number] => 20080299116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/107041 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14750 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299116.pdf [firstpage_image] =>[orig_patent_app_number] => 12107041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422052 [patent_doc_number] => 20090148507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Chimeric polypeptides containing chemokine domains' [patent_app_type] => utility [patent_app_number] => 12/148143 [patent_app_country] => US [patent_app_date] => 2008-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14308 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148507.pdf [firstpage_image] =>[orig_patent_app_number] => 12148143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297126 [patent_doc_number] => 20090012052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'METHOD FOR TREATING ER+ BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/100053 [patent_app_country] => US [patent_app_date] => 2008-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18938 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012052.pdf [firstpage_image] =>[orig_patent_app_number] => 12100053 [rel_patent_id] =>[rel_patent_doc_number] =>)